Gene selective suppression of nonsense termination using antisense agents

Biochimica et Biophysica Acta - Gene Structure and Expression

Volumn 1730, Issue 3, 2005, Pages 165-172

  Kulyté, Agné ^a   Dryselius, Rikard ^a   Karlsson, Jenny ^a   Good, Liam ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Antisense; Nonsense suppression; Peptide nucleic acid; Readthrough; Translation termination

Indexed keywords

GENTAMICIN; LUCIFERASE; MESSENGER RNA; PAROMOMYCIN; PEPTIDE NUCLEIC ACID; PROTEIN LUXB; UNCLASSIFIED DRUG;

ARTICLE; CELL FUNCTION; CELL GROWTH; CONTROLLED STUDY; ENZYME ACTIVITY; ESCHERICHIA COLI; EXPERIMENTATION; GENE REPRESSION; HYPOTHESIS; NONHUMAN; NONSENSE MUTATION; NUCLEIC ACID PROBE; PLASMID; PRIORITY JOURNAL; REPORTER GENE; RIBOSOME; RNA TRANSLATION; STEREOSPECIFICITY; STOP CODON;

ANTI-BACTERIAL AGENTS; CODON, NONSENSE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESCHERICHIA COLI; GENES, BACTERIAL; GENES, REPORTER; GENES, SUPPRESSOR; GENTAMICINS; LUCIFERASES; MUTATION; PAROMOMYCIN; PLASMIDS; RNA, MESSENGER;

ESCHERICHIA COLI;

EID: 24944536733     PISSN: 01674781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbaexp.2005.07.004     Document Type: Article

References (37)

1. V.A. Kusick Mendelian Inheritance in Man: A Catalog of Human Genes and Genetic Disorders 1998 Johns Hopkins University Press Baltimore
2. R. Ayyagari, F.Y. Demirci, J. Liu, E.L. Bingham, H. Stringham, L.E. Kakuk, M. Boehnke, M.B. Gorin, J.E. Richards, and P.A. Sieving X-linked recessive atrophic macular degeneration from RPGR mutation Genomics 80 2002 166 171
3. R.G. Roberts, R.J. Gardner, and M. Bobrow Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations Hum. Mutat. 4 1994 1 11
4. Y. Takeshima, H. Wada, M. Yagi, Y. Ishikawa, R. Minami, H. Nakamura, and M. Matsuo Oligonucleotides against a splicing enhancer sequence led to dystrophin production in muscle cells from a Duchenne muscular dystrophy patient Brain Dev. 23 2001 788 790
5. J.C. van Deutekom, M. Bremmer-Bout, A.A. Janson, I.B. Ginjaar, F. Baas, J.T. den Dunnen, and G.J. van Ommen Antisense-induced exon skipping restores dystrophin expression in DMD patient derived muscle cells Hum. Mol. Genet. 10 2001 1547 1554
6. R. Kapsa, A. Quigley, G.S. Lynch, K. Steeper, A.J. Kornberg, P. Gregorevic, L. Austin, and E. Byrne In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement Hum. Gene Ther. 12 2001 629 642
7. M. Howard, T. Jilling, M. DuVall, and R.A. Frizzell cAMP-regulated trafficking of epitope-tagged CFTR Kidney Int. 49 1996 1642 1648
8. D.C. Eustice, and J.M. Wilhelm Fidelity of the eukaryotic codon-anticodon interaction: interference by aminoglycoside antibiotics Biochemistry 23 1984 1462 1467
9. R. Schroeder, C. Waldsich, and H. Wank Modulation of RNA function by aminoglycoside antibiotics EMBO J. 19 2000 1 9
10. A. Zsembery, W. Jessner, G. Sitter, C. Spirli, M. Strazzabosco, and J. Graf Correction of CFTR malfunction and stimulation of Ca-activated Cl channels restore HCO3-secretion in cystic fibrosis bile ductular cells Hepatology 35 2002 95 104
11. K.M. Keeling, D.A. Brooks, J.J. Hopwood, P. Li, J.N. Thompson, and D.M. Bedwell Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of alpha-l-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation Hum. Mol. Genet. 10 2001 291 299
12. D.M. Bedwell, A. Kaenjak, D.J. Benos, Z. Bebok, J.K. Bubien, J. Hong, A. Tousson, J.P. Clancy, and E.J. Sorscher Suppression of a CFTR premature stop mutation in a bronchial epithelial cell line Nat. Med. 3 1997 1280 1284
13. M. Wilschanski, Y. Yahav, Y. Yaacov, H. Blau, L. Bentur, J. Rivlin, M. Aviram, T. Bdolah-Abram, Z. Bebok, L. Shushi, B. Kerem, and E. Kerem Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations N. Engl. J. Med. 349 2003 1433 1441
14. J.P. Clancy, Z. Bebok, F. Ruiz, C. King, J. Jones, L. Walker, H. Greer, J. Hong, L. Wing, M. Macaluso, R. Lyrene, E.J. Sorscher, and D.M. Bedwell Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis Am. J. Respir. Crit. Care Med. 163 2001 1683 1692
15. L. Politano, G. Nigro, V. Nigro, G. Piluso, S. Papparella, O. Paciello, and L.I. Comi Gentamicin administration in Duchenne patients with premature stop codon. Preliminary results Acta Myol. 22 2003 15 21
16. K.R. Wagner, S. Hamed, D.W. Hadley, A.L. Gropman, A.H. Burstein, D.M. Escolar, E.P. Hoffman, and K.H. Fischbeck Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations Ann. Neurol. 49 2001 706 711
17. R.J. Kaufman Correction of genetic disease by making sense from nonsense J. Clin. Invest. 104 1999 367 368
18. J.F. Curran, and M. Yarus Use of tRNA suppressors to probe regulation of Escherichia coli release factor 2 J. Mol. Biol. 203 1988 75 83
19. L. Kisselev, M. Ehrenberg, and L. Frolova Termination of translation: interplay of mRNA, rRNAs and release factors? EMBO J 22 2003 175 182
20. Y. Nakamura, and K. Ito Making sense of mimic in translation termination Trends Biochem. Sci. 28 2003 99 105
21. M.T. Howard, R.F. Gestel, and J.F. Atkins Efficient stimulation of site-specific ribosome frameshifting by antisense oligonucleotides RNA 10 2004 1653 1661
22. P. Steneberg, and C. Samakovlis A novel stop codon readthrough mechanism produces functional Headcase protein in Drosophila trachea EMBO Rep. 2 2001 593 597
23. D.W. Schultz, and M. Yarus A simple and sensitive in vivo luciferase assay for tRNA-mediated nonsense suppression J. Bacteriol. 172 1990 595 602
24. L. Good, and P.E. Nielsen Progress in developing PNA as a gene-targeted drug Antisense Nucleic Acid Drug Dev. 7 1997 431 437
25. M. Sekiguchi, and S. Iida Mutants of Escherichia coli permeable to actinomycin Proc. Natl. Acad. Sci. U. S. A. 58 1967 2315 2320
26. L. Good, S.K. Awasthi, R. Dryselius, O. Larsson, and P.E. Nielsen Bactericidal antisense effects of peptide-PNA conjugates Nat. Biotechnol. 19 2001 360 364
27. AppliedBiosystems, Relative Quantitation Of Gene Expression: ABI PRISM 7700 Sequence Detection System: User Bulletin #2, 1997.
28. R. Martin, A.E. Mogg, L.A. Heywood, L. Nitschke, and J.F. Burke Aminoglycoside suppression at UAG, UAA and UGA codons in Escherichia coli and human tissue culture cells Mol. Gen. Genet. 217 1989 411 418
29. M.T. Howard, B.H. Shirts, L.M. Petros, K.M. Flanigan, R.F. Gestel, and J.F. Atkins Sequence specificity of aminoglycoside-induced stop condon readthrough: potential implications for treatment of Duchenne muscular dystrophy Ann. Neurol. 48 2000 164 169
30. M. Manuvakhova, K. Keeling, and D.M. Bedwell Aminoglycoside antibiotics mediate context-dependent suppression of termination codons in a mammalian translation system RNA 6 2000 1044 1055
31. J. Thompson, M. O'Connor, J.A. Mills, and A.E. Dahlberg The protein synthesis inhibitors, oxazolidinones and chloramphenicol, cause extensive translational inaccuracy in vivo J. Mol. Biol. 322 2002 273 279
32. J.M. Ogle, A.P. Carter, and V. Ramakrishnan Insights into the decoding mechanism from recent ribosome structures Trends Biochem. Sci. 28 2003 259 266
33. L. Bidou, I. Hatin, N. Perez, V. Allamand, J.J. Panthier, and J.P. Rousset Premature stop codons involved in muscular dystrophies show a broad spectrum of readthrough efficiencies in response to gentamicin treatment Gene Ther. 119 2004 619 627
34. A. Bjornsson, S. Mottagui-Tabar, and L.A. Isaksson The analysis of translational activity using a reporter gene constructed from repeats of an antibody-binding domain from protein A Methods Mol. Biol. 77 1998 75 91
35. G. Bertram, S. Innes, O. Minella, J. Richardson, and I. Stansfield Endless possibilities: translation termination and stop codon recognition Microbiology 147 2001 255 269
36. S. Tork, I. Hatin, J.P. Rousset, and C. Fabret The major 5′ determinant in stop codon read-through involves two adjacent adenines Nucleic Acids Res. 32 2004 415 421
37. S.R. Kushner mRNA decay in prokaryotes and eukaryotes: different approaches to a similar problem IUBMB Life 56 2004 585 594